(Q37193446)
Statements
1 reference
Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X). (English)
1 reference
Julio Rosenstock
1 reference
John E Gerich
1 reference
Denis Raccah
1 reference
László Korányi
1 reference
Laura Maffei
1 reference
Gabor Boka
1 reference
Patrick Miossec
1 reference
1 reference
1 reference
Identifiers
1 reference